Postprandial HyperglycemiaNCT05405010
Individually Timed Stair Climbing and Descending to Lower Postprandial Glucose
A study testing Stair climbing and descending for 1 minute and Stair climbing and descending for 3 minutes in people with Postprandial Hyperglycemia and Postprandial Insulin, run by San Diego State University at 1 site in United States.
Trial summary
Effect of individually timed exercise to attenuate postprandial glucose excursions Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Postprandial Hyperglycemia, Postprandial Insulin
- What is being tested?
- Stair climbing and descending for 1 minute and Stair climbing and descending for 3 minutes
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 22 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Sep 2019to 1 Sep 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- between 18 and 65 years
Who cannot join
- high-risk from PAR-Q
Trial locations and contacts
1 site in 1 country.
United States1 site
San Diego State University
San Diego, California, 92182
About this study
Effect of individually timed exercise to attenuate postprandial glucose excursions
Read the detailed description
Participants will perform 1 and 3 minutes stair climbing and descending at a self-selected pace after a mixed meal on separate visits. The timing of these exercise bouts will be determined from an initial control condition where the participant remains seated. Timing of exercise will coincide with the peak glucose from the control condition. Glucose will be measured every 10 minutes.
- Conditions
- Postprandial Hyperglycemia, Postprandial Insulin
- Being tested
- Stair climbing and descending for 1 minute, Stair climbing and descending for 3 minutes, Seated control
- Medical subject headings
- Hyperglycemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stair climbing and descending for 1 minuteOther
Stair climbing and descending for 1 minute
Stair climbing and descending for 3 minutesOther
Stair climbing and descending for 3 minutes
Seated controlOther
Seated control
| Study group | Role | What they receive |
|---|---|---|
| Control | Placebo comparator | Participants remain seated for 1 hour Receives: Other: Seated control |
| 1 min | Experimental | Participants remain seated for 1 hour except for 1 minute of stair climbing and descending Receives: Other: Stair climbing and descending for 1 minute |
| 3 min | Experimental | Participants remain seated for 1 hour except for 3 minute of stair climbing and descending Receives: Other: Stair climbing and descending for 3 minutes |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postprandial Glucose
mg/dL
Measured: 1 hour
Secondary outcomes (1)
Postprandial insulin
iu
Measured: 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2022
- Study start1 Sep 2019
- Primary completion1 Sep 2020
- Study completion1 Sep 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postprandial HyperglycemiaStudies of the same condition, open and under way.
- More trials run by San Diego State UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 22 participants (actual)
Sponsor and investigators
- Lead sponsor
- San Diego State University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jeff Moore, San Diego State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05405010
- Sponsor's protocol ID
- UniquePeakSCD
- Status last verified
- Feb 2023
- First submitted
- 31 May 2022
- Last updated
- 9 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Individually Timed Stair Climbing and Descending to Lower Postprandial Glucose
- ClinicalTrials.gov ID
- NCT05405010
- Acronym / sponsor ID
- UniquePeakSCD
- Conditions
- Postprandial Hyperglycemia, Postprandial Insulin
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 22 participants (actual)
- Lead sponsor
- San Diego State UniversityUniversity, hospital or other
- Study start
- 1 Sep 2019 (actual)
- Primary completion
- 1 Sep 2020 (actual)
- Study completion
- 1 Sep 2020 (actual)
- First posted
- 3 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Effect of individually timed exercise to attenuate postprandial glucose excursions
Detailed description
Participants will perform 1 and 3 minutes stair climbing and descending at a self-selected pace after a mixed meal on separate visits. The timing of these exercise bouts will be determined from an initial control condition where the participant remains seated. Timing of exercise will coincide with the peak glucose from the control condition. Glucose will be measured every 10 minutes.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Control | Placebo comparator | Other: Seated controlParticipants remain seated for 1 hour |
| 1 min | Experimental | Other: Stair climbing and descending for 1 minuteParticipants remain seated for 1 hour except for 1 minute of stair climbing and descending |
| 3 min | Experimental | Other: Stair climbing and descending for 3 minutesParticipants remain seated for 1 hour except for 3 minute of stair climbing and descending |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- between 18 and 65 years
Key exclusion criteria (1 listed)
- high-risk from PAR-Q
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stair climbing and descending for 1 minuteStair climbing and descending for 1 minute | Other | 1 min |
| Stair climbing and descending for 3 minutesStair climbing and descending for 3 minutes | Other | 3 min |
| Seated controlSeated control | Other | Control |
Primary outcome
Postprandial Glucose
Time frame: 1 hour
mg/dL
1 secondary outcome
Postprandial insulin
Time frame: 1 hour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2023.
- Individual participant dataSharing planned: No
Related trials for Postprandial Hyperglycemia
Active, not recruiting
How Fig Polyphenols Affect Blood Sugar and Insulin Levels After Eating in Adults at Risk for Diabetes
Pre Diabetic
Enrolling by invitation
Development of Anti-Diabetic Nutraceuticals From Legume Seed Coats
Postprandial Hyperglycemia, Type 2 Diabetes
Active, not recruiting
Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults
Postprandial Hyperglycemia, Hyperinsulinemia
Recruiting
Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring
Postprandial Glucose, Glucose Levels
Not yet recruiting
Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism
Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (Prediabetes)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Stair climbing and descending for 1 minute and Stair climbing and descending for 3 minutes in people with Postprandial Hyperglycemia and Postprandial Insulin, run by San Diego State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postprandial Glucose (time frame: 1 hour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2023.